HCW Biologics Inc. (HCWB)
1.68
-0.01
(-0.59%)
USD |
NASDAQ |
Oct 02, 16:00
1.65
-0.03
(-1.79%)
After-Hours: 06:59
HCW Biologics Net Income (Quarterly) : -15.37M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.37M |
| March 31, 2026 | 1.256M |
| December 31, 2025 | -3.466M |
| September 30, 2025 | -4.554M |
| June 30, 2025 | -12.08M |
| March 31, 2025 | -2.197M |
| December 31, 2024 | -3.373M |
| September 30, 2024 | -3.902M |
| June 30, 2024 | -15.28M |
| March 31, 2024 | -7.468M |
| December 31, 2023 | -10.68M |
| September 30, 2023 | -4.939M |
| June 30, 2023 | -4.304M |
| Date | Value |
|---|---|
| March 31, 2023 | -5.071M |
| December 31, 2022 | -5.419M |
| September 30, 2022 | -3.914M |
| June 30, 2022 | -3.511M |
| March 31, 2022 | -2.057M |
| December 31, 2021 | -3.173M |
| September 30, 2021 | -4.095M |
| June 30, 2021 | -2.750M |
| March 31, 2021 | -2.844M |
| September 30, 2020 | -2.709M |
| June 30, 2020 | -2.778M |
| March 31, 2020 | -2.376M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.1356M |
| Total Expenses (Quarterly) | 15.51M |
| EPS Diluted (Quarterly) | -11.58 |
| Enterprise Value | 8.538M |
| Gross Profit Margin (Quarterly) | -163.0% |
| Profit Margin (Quarterly) | -11.34K% |
| Earnings Yield | -1.69K% |
| Normalized Earnings Yield | -1837.11 |